Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Am J Perinatol ; 2023 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-37657486

RESUMEN

OBJECTIVE: Fortification of human milk (HM) with either human milk-derived fortifier (HMDF) or cow milk-derived fortifier (CMDF) is important in preterm infants. The objective is to compare the incidence of hypoglycemia, and biochemical values in infants less than 1,250 g at birth fed HMDF versus CMDF. STUDY DESIGN: It is a retrospective cohort study on infants less than 1,250 g at birth who were fed with HMDF or CMDF. Hypoglycemia was defined as blood glucose (BG) level equal to or less than 60 mg/dL within 72 hours of full enteral feeds when off total parenteral nutrition and intravenous fluids. RESULTS: Ninety infants were enrolled (HMDF = 61, CMDF = 29). HMDF group had a higher rate of hypoglycemia (46 vs. 24%; p = 0.048) after achievement of full enteral feeding. The median minimum BG was lower (61 vs. 71; p ≤ 0.01), while blood urea nitrogen (12 vs. 6; p ≤ 0.01) and albumin (3.1 vs. 2.7; p ≤ 0.01) were higher in HMDF group compared with CMDF. CONCLUSION: At full enteral feedings in infants less than 1,250 g at birth, an HMDF diet may predispose to hypoglycemia needing intervention. Close monitoring of BG levels once off parenteral nutrition is recommended. KEY POINTS: · Exclusive human milk (EHM) feeding results in better nutritional indices.. · EHM feeding at higher calorie/ounce improves growth.. · Blood glucose needs to be monitored when off TPN during EHM feeding..

3.
J Perinatol ; 40(2): 248-255, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31611614

RESUMEN

OBJECTIVE: To compare outcomes of twin-twin transfusion syndrome (TTTS) patients who underwent early elective delivery vs. expectant management. STUDY DESIGN: Retrospective study of monochorionic diamniotic twins who underwent laser surgery for TTTS and had dual survivors at 32 weeks. Patients who underwent elective delivery between 32 0/7 to 35 6/7 weeks ("early elective group") were compared with all patients who delivered ≥36 0/7 weeks ("expectant management group"). The primary outcome was a composite of fetal and neonatal morbidity. RESULTS: The final study population was comprised of 15 early elective and 119 expectant management patients. Those in the early elective group were seven times more likely to experience the primary outcome (OR 7.38 [2.01-27.13], p = 0.0026). CONCLUSION: Among patients who underwent laser surgery for TTTS who had dual survivors at 32 weeks, elective delivery prior to 36 weeks did not appear to be protective.


Asunto(s)
Parto Obstétrico , Enfermedades en Gemelos/cirugía , Transfusión Feto-Fetal/cirugía , Enfermedades del Recién Nacido/epidemiología , Terapia por Láser , Cesárea , Enfermedades en Gemelos/epidemiología , Procedimientos Quirúrgicos Electivos , Femenino , Muerte Fetal , Edad Gestacional , Humanos , Lactante , Muerte del Lactante/prevención & control , Recién Nacido , Modelos Logísticos , Embarazo , Embarazo Gemelar , Nacimiento Prematuro , Estudios Retrospectivos , Factores de Tiempo , Gemelos Monocigóticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA